These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25148808)

  • 1. Regulated necrosis.
    Kroemer G
    Semin Cell Dev Biol; 2014 Nov; 35():1. PubMed ID: 25148808
    [No Abstract]   [Full Text] [Related]  

  • 2. Necroptosis, in vivo detection in experimental disease models.
    Jouan-Lanhouet S; Riquet F; Duprez L; Vanden Berghe T; Takahashi N; Vandenabeele P
    Semin Cell Dev Biol; 2014 Nov; 35():2-13. PubMed ID: 25160988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of regulated necrosis.
    Galluzzi L; Kepp O; Krautwald S; Kroemer G; Linkermann A
    Semin Cell Dev Biol; 2014 Nov; 35():24-32. PubMed ID: 24582829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed necrosis and necroptosis signalling.
    Feoktistova M; Leverkus M
    FEBS J; 2015 Jan; 282(1):19-31. PubMed ID: 25327580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive roles of receptor-interacting protein kinases 1 and 3 in caspase-independent cell death of L929.
    Park SY; Shim JH; Cho YS
    Cell Biochem Funct; 2014 Jan; 32(1):62-9. PubMed ID: 23584955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RIP kinase 3 in necroptosis: does it take two or more to kill?
    Kim C; Pasparakis M
    Cell Death Differ; 2014 Oct; 21(10):1505-7. PubMed ID: 25196971
    [No Abstract]   [Full Text] [Related]  

  • 7. The flick of a switch: which death program to choose?
    Vandenabeele P; Melino G
    Cell Death Differ; 2012 Jul; 19(7):1093-5. PubMed ID: 22684093
    [No Abstract]   [Full Text] [Related]  

  • 8. [Expressions of receptor-interacting protein and caspase-8 in oral squamous cell carcinoma and oral precancerous lesions].
    Shi YJ; Shen LJ; Yin C
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Sep; 29(9):1802-5. PubMed ID: 19778795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RIPK1 promotes death receptor-independent caspase-8-mediated apoptosis under unresolved ER stress conditions.
    Estornes Y; Aguileta MA; Dubuisson C; De Keyser J; Goossens V; Kersse K; Samali A; Vandenabeele P; Bertrand MJ
    Cell Death Dis; 2014 Dec; 5(12):e1555. PubMed ID: 25476903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome.
    Kang TB; Yang SH; Toth B; Kovalenko A; Wallach D
    Immunity; 2013 Jan; 38(1):27-40. PubMed ID: 23260196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necroptosis: an emerging form of programmed cell death.
    Wu W; Liu P; Li J
    Crit Rev Oncol Hematol; 2012 Jun; 82(3):249-58. PubMed ID: 21962882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytically active Yersinia outer protein P induces cleavage of RIP and caspase-8 at the level of the DISC independently of death receptors in dendritic cells.
    Gröbner S; Adkins I; Schulz S; Richter K; Borgmann S; Wesselborg S; Ruckdeschel K; Micheau O; Autenrieth IB
    Apoptosis; 2007 Oct; 12(10):1813-25. PubMed ID: 17624595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RIPK3 regulates p62-LC3 complex formation via the caspase-8-dependent cleavage of p62.
    Matsuzawa Y; Oshima S; Nibe Y; Kobayashi M; Maeyashiki C; Nemoto Y; Nagaishi T; Okamoto R; Tsuchiya K; Nakamura T; Watanabe M
    Biochem Biophys Res Commun; 2015 Jan; 456(1):298-304. PubMed ID: 25450619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL.
    Lawlor KE; Khan N; Mildenhall A; Gerlic M; Croker BA; D'Cruz AA; Hall C; Kaur Spall S; Anderton H; Masters SL; Rashidi M; Wicks IP; Alexander WS; Mitsuuchi Y; Benetatos CA; Condon SM; Wong WW; Silke J; Vaux DL; Vince JE
    Nat Commun; 2015 Feb; 6():6282. PubMed ID: 25693118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-alpha induces two distinct caspase-8 activation pathways.
    Wang L; Du F; Wang X
    Cell; 2008 May; 133(4):693-703. PubMed ID: 18485876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New autoinflammatory disease caused by non-cleavable RIPK1 variants.
    Onuora S
    Nat Rev Rheumatol; 2020 Feb; 16(2):61. PubMed ID: 31911632
    [No Abstract]   [Full Text] [Related]  

  • 17. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis.
    Rickard JA; O'Donnell JA; Evans JM; Lalaoui N; Poh AR; Rogers T; Vince JE; Lawlor KE; Ninnis RL; Anderton H; Hall C; Spall SK; Phesse TJ; Abud HE; Cengia LH; Corbin J; Mifsud S; Di Rago L; Metcalf D; Ernst M; Dewson G; Roberts AW; Alexander WS; Murphy JM; Ekert PG; Masters SL; Vaux DL; Croker BA; Gerlic M; Silke J
    Cell; 2014 May; 157(5):1175-88. PubMed ID: 24813849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance.
    Kaczmarek A; Vandenabeele P; Krysko DV
    Immunity; 2013 Feb; 38(2):209-23. PubMed ID: 23438821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ripoptosome: a novel IAP-regulated cell death-signalling platform.
    Imre G; Larisch S; Rajalingam K
    J Mol Cell Biol; 2011 Dec; 3(6):324-6. PubMed ID: 22114055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism.
    Murphy JM; Czabotar PE; Hildebrand JM; Lucet IS; Zhang JG; Alvarez-Diaz S; Lewis R; Lalaoui N; Metcalf D; Webb AI; Young SN; Varghese LN; Tannahill GM; Hatchell EC; Majewski IJ; Okamoto T; Dobson RC; Hilton DJ; Babon JJ; Nicola NA; Strasser A; Silke J; Alexander WS
    Immunity; 2013 Sep; 39(3):443-53. PubMed ID: 24012422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.